- Home
- RNA vs IAG Comparison
RNA vs IAG Comparison
Compare RNA & IAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RNA | IAG |
|---|---|---|
| Founded | 2012 | 1990 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 13.1B |
| IPO Year | 2025 | 2002 |
Fundamental Metrics
Financial Performance| Metric | RNA | IAG |
|---|---|---|
| Price | $14.93 | $21.71 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 20 | 4 |
| Target Price | ★ $69.26 | $17.75 |
| AVG Volume (30 Days) | 2.9M | ★ 7.4M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $88.12 | $44.84 |
| Revenue Next Year | $18.11 | $1.33 |
| P/E Ratio | ★ N/A | $18.66 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $13.06 | $5.02 |
| 52 Week High | $73.06 | $24.87 |
Technical Indicators
Market Signals| Indicator | RNA | IAG |
|---|---|---|
| Relative Strength Index (RSI) | 4.22 | 50.99 |
| Support Level | $13.06 | $16.22 |
| Resistance Level | $72.52 | $22.47 |
| Average True Range (ATR) | 0.83 | 1.10 |
| MACD | -6.15 | -0.24 |
| Stochastic Oscillator | 3.11 | 37.94 |
Price Performance
Historical ComparisonAbout RNA Avidity Biosciences Inc.
Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. The company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.
About IAG Iamgold Corporation
Iamgold Corp is a mid-tier gold mining company. The company operating gold mines are divided into geographic segments such as Cote Gold mine - Canada, Burkina Faso - Essakane mine, Westwood mine - Canada. The company's s non-gold mine segments are Exploration and evaluation and development, and Corporate - which includes royalty interests. The company generates the majority of its revenue from the Cote Gold mine segment.